Table 1.

Biochemical profile of the hyperthyroid patients’ pre- and post-treatment using carbimazole as antithyroid medication.

Parameters	Hyperthyroid	Euthyroid	p-value
Patients number	20
Age (years)	40 ± 11.5
Glucose (mmol/L)	5.5 ± 0.7	5.6 ± 0.6	0.63
Urea (mmol/L)	4.6 ± 0.5	4.8 ± 0.5	0.21
Creatinine (umol/L)	62.1 ± 10.7	65.8 ± 11.0	0.45
Sodium (mmol/L)	139.2 ± 1.9	139.1 ± 0.4	0.81
Potassium (mmol/L)	4.4 ± 0.1	4.4 ± 0.2	1.00
Aspartate transaminase (IU/L)	33.9 ± 8.9	30.6 ± 4.2	0.30
Alanine transaminase (IU/L)	17.1 ± 4.8	15.2 ± 1.9	0.25
Alkaline phosphatase (IU/L)	113.9 ± 52.9	119.8 ± 28.4	0.76
FT4 (pmol/L)	34.9 ± 9.8	16.9 ± 2.9	< 0.0001*
TSH (mIU/L)	0.014 ± 0.02	0.7 ± 0.5	< 0.0001*
Total cholesterol (mmol/L)	4.5 ± 1.2	4.8 ± 1.0	0.55
LDL cholesterol (mmol/L)	2.6 ± 0.8	3.0 ± 0.8	0.27
TG (mmol/L)	1.0 ± 0.7	0.8 ± 0.5	0.31
HDL cholesterol (mmol/L)	1 ± 0.3	1.3 ± 0.3	0.03*

^*Indicate statistically significant alterations (p-value < 0.05).

FT4, free thyroxine; TSH, thyroid-stimulating hormone; LDL, low-density lipoprotein; TG, triglycerides; HDL, high-density lipoprotein.